In order to silence the expression levels of pathogenic genes, small interfering RNA (siRNA) requires a nano-sized carrier for its safe and stable delivery into cells. In this research highlight, we focus on well-defined cationic nanohydrogel particles developed in our group for such purposes. To investigate the nanogels’ mechanism for enhanced knockdown efficiencies, we recently synthesized two sets of particles with similar material composition and siRNA-loading characteristics, but – according to the manufacturing process – of different sizes. Within this study, 100-nm-sized nanogel particles loaded with siRNA accumulated inside the lysosomes already after 4 h and could not induce any gene knockdown, while 40-nm-sized particles were able...
The mesoporous silica nanoparticle (MSN) has been utilized for various drug delivery systems. For th...
In recent year, researches in gene therapy have witnessed several potential therapeutic approaches b...
Abstract Short pharmaceutical active oligonucleotides such as small interfering RNA (siRNA) or cytid...
lt;pgt;In order to silence the expression levels of pathogenic genes, small interfering RNA (siRNA) ...
To overcome the poor pharmacokinetic conditions of short double-stranded RNA molecules in RNA interf...
RNA interference (RNAi) certainly is a hot topic among the scientific community, judging by the broa...
RNA interference (RNAi) is a powerful tool to treat diseases and elucidate target gene function. Pri...
The successful therapeutic application of small interfering RNA (siRNA) largely relies on the develo...
A critical need still remains for effective delivery of RNA interference (RNAi) therapeutics to targ...
Diseases and disorders may be treated through RNA interference (RNAi), a natural post-transcriptiona...
Encapsulating drug molecules, and selectively delivering those drugs to a disease site, is a complex...
Cytosolic delivery remains a major bottleneck for siRNA therapeutics. To facilitate delivery, siRNAs...
Nanometer-size gel particles, or nanogels, have potential for delivering therapeutic macromolecules....
RNA interference (RNAi) is a cellular process whereby the silencing of a particular gene is mediated...
A critical need still remains for effective delivery of RNA interference (RNAi) therapeutics to targ...
The mesoporous silica nanoparticle (MSN) has been utilized for various drug delivery systems. For th...
In recent year, researches in gene therapy have witnessed several potential therapeutic approaches b...
Abstract Short pharmaceutical active oligonucleotides such as small interfering RNA (siRNA) or cytid...
lt;pgt;In order to silence the expression levels of pathogenic genes, small interfering RNA (siRNA) ...
To overcome the poor pharmacokinetic conditions of short double-stranded RNA molecules in RNA interf...
RNA interference (RNAi) certainly is a hot topic among the scientific community, judging by the broa...
RNA interference (RNAi) is a powerful tool to treat diseases and elucidate target gene function. Pri...
The successful therapeutic application of small interfering RNA (siRNA) largely relies on the develo...
A critical need still remains for effective delivery of RNA interference (RNAi) therapeutics to targ...
Diseases and disorders may be treated through RNA interference (RNAi), a natural post-transcriptiona...
Encapsulating drug molecules, and selectively delivering those drugs to a disease site, is a complex...
Cytosolic delivery remains a major bottleneck for siRNA therapeutics. To facilitate delivery, siRNAs...
Nanometer-size gel particles, or nanogels, have potential for delivering therapeutic macromolecules....
RNA interference (RNAi) is a cellular process whereby the silencing of a particular gene is mediated...
A critical need still remains for effective delivery of RNA interference (RNAi) therapeutics to targ...
The mesoporous silica nanoparticle (MSN) has been utilized for various drug delivery systems. For th...
In recent year, researches in gene therapy have witnessed several potential therapeutic approaches b...
Abstract Short pharmaceutical active oligonucleotides such as small interfering RNA (siRNA) or cytid...